Cargando…
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Autores principales: | Olofsson Bagge, Roger, Ny, Lars, All-Ericsson, Charlotta, Sternby Eilard, Malin, Rizell, Magnus, Cahlin, Christian, Stierner, Ulrika, Lönn, Ulf, Hansson, Johan, Ljuslinder, Ingrid, Lundgren, Lotta, Ullenhag, Gustav, Kiilgaard, Jens Folke, Nilsson, Jonas, Lindnér, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527346/ https://www.ncbi.nlm.nih.gov/pubmed/26246135 http://dx.doi.org/10.1186/s13063-015-0809-8 |
Ejemplares similares
-
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
por: Olofsson, Roger, et al.
Publicado: (2014) -
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
por: Olofsson Bagge, Roger, et al.
Publicado: (2023) -
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
por: Jespersen, Henrik, et al.
Publicado: (2019) -
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
por: Ny, Lars, et al.
Publicado: (2021) -
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
por: Eilard, Malin Sternby, et al.
Publicado: (2019)